tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ACAD is currently covered by 15 analysts with an average price target of $31.75. This is a potential upside of $6.92 (7.96%) from yesterday's end of day stock price of $29.41.
ACADIA Pharmaceuticals's activity chart (see below) currently has 422 price targets and 340 ratings on display. The stock rating distribution of ACAD is 30% HOLD and 70% BUY.
Analysts average stock forecasts to be materialized ratio is 59.19% with an average time for these price targets to be met of 253.83 days.
Highest price target for ACAD is $40, Lowest price target is $23, average price target is $31.75.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 09-Aug-2026. First documented stock forecast 06-May-2013.
Currently out of the existing stock ratings of ACAD, 12 are a HOLD (30%), 28 are a BUY (70%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Oct-2025
$39
$9.61 (32.70%)
$35
Hold Since 04-Aug-2026
$25
$-4.39 (-14.94%)
$22
Buy Since 22-Jun-2025
$37
$7.61 (25.89%)
$36
Buy Since 16-Apr-2025
$36
$6.61 (22.49%)
$26
Hold Since 19-Jun-2022
$25
$-4.39 (-14.94%)
$24
What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?
